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‘‘The truth is rarely pure and never simple.’’
Oscar Wilde (1854–1900), The Importance of Being Earnest,
1895, Act I
The entity pediatric autoimmune neuropsychiatric disorders
associated with streptococcal infections (PANDAS) was initially
proposed in 1998.1 The formal diagnosis required that the affected
individual meet five specific criteria: prepubertal onset, obsessive
compulsive disorder (OCD) and/or a tic disorder, the dramatic sudden
explosive onset of symptoms, a relapsing and remitting course of
symptoms that are temporally associated with Group A beta-hemolytic
streptococcal (GABHS) infection, and the presence of other neurop-
sychiatric abnormalities (hyperactivity, emotional lability, anxiety, or
piano-playing choreiform movements). Since that original report, the
PANDAS hypothesis has remained controversial on the basis of both
clinical grounds and failure to confirm a definitive immune process.
In their report,2 Helm and Blackwood describe their experience
with PANDAS from the perspective of a pediatric division of infectious
disease. The authors’ conclusion, that the majority of patients (76%)
referred with a pre-diagnosis of PANDAS did not fulfill diagnostic
criteria, confirms that described in other reports.3 Hence, one logical
outcome, as stated in their manuscript, is the need to improve the
‘‘current deficit in physician knowledge’’ about this diagnosis. All are
in agreement that the misdiagnosis of PANDAS has the potential to
lead to the unnecessary use of various treatments (antibiotics,
Intravenous immunoglobulin (IVIG), and plasmapheresis) and needs
to be rectified.
That said, what about the five children that were said to fulfill the
criteria for PANDAS? An important question is whether there is
sufficient data available to support the diagnosis in these individuals.
Granted, the authors were not the primary caregivers, but in any
controversial disorder, it is essential that all core information be
available. In four of the five described PANDAS cases, the explosive
onset included tics, but were they pre-existing symptoms? Some have
suggested that the presence of prior tics should exclude the diagnosis of
PANDAS. Others, recognizing the often variable nature of tics, have
excluded them as a major diagnostic category in the broadened PANS
(pediatric acute-onset neuropsychiatric syndrome) criteria.4 Similar
questions can be raised about the two reported children with Attention
Deficit Hyperactivity Disorder (ADHD). In a multicenter longitudinal
study of children with PANDAS, tic/OCD exacerbations were not
associated with an increase in the severity of psychiatric comorbidity,
including motoric hyperactivity, emotional lability, intense anxiety,
cognitive deficits, or oppositional behaviors.5
Moving to criterion 5 (other ‘‘neuropsychiatric abnormalities’’),
Helm and Blackwood do not provide information about the presence
or absence of piano-playing choreiform movements. In the original
published PANDAS cohort, no individual had ‘‘overt chorea,’’ but all
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except one had choreiform movements and 50% had ‘‘marked
choreiform’’ movements.1 Admittedly, the absence of choreiform
movements does not negate the possibility of PANDAS, recognizing
that two differing subgroups of children fulfilling the original proposed
criteria for PANDAS have been reported: 1) the original cohort,
displaying choreiform piano-playing movements (PANDAS-chorei-
form), and 2) a PANDAS-chronic tics and OCD cohort that includes
children with at least two prior acute fulminant episodes of tics or
OCD in a temporal association with a GABHS infection, but lacking
piano-playing movements.6 This distinction may actually be very
significant, recognizing that the PANDAS-choreiform cohort has
biomarkers very similar to Sydenham’s chorea (elevated anti-
dopamine 1 receptor (D1R) and anti-dopamine 2 receptor (D2R)
immunoglobulin (Ig)G levels and possibly elevated anti-lysoganglio-
side-GM1), whereas the PANDAS-chronic tics and OCD group has
normal levels of antibodies to tubulin and D2R, and control group-
dependent alterations of anti-D1R and lysoganglioside-GM1, i.e.
unchanged compared to a large (n570) multicenter control but
differing from a smaller (n515) previously published control group.6
The essential characteristic of PANDAS is the temporal association
between the onset and exacerbation of tic or OCD symptoms and a
GABHS infection. Is there sufficient information in the 5 Helm and
Blackwell case’s confirming the recurrence of symptoms within several
weeks of a new GABHS infection? In four out of five, there was ‘‘at
least one documented elevated anti-streptococcal titer,’’ but what levels
were considered elevated? This is important, since levels of these
antibodies are normally higher among school age children than
adults.7 Additionally, as noted by the authors, 56% of those
misdiagnosed as PANDAS also had elevated anti-streptococcal titers.
Prior investigators have emphasized that the use of single-point-in-time
assessments of anti-streptococcal antibodies is unacceptable and that a
new infection should be confirmed by a significant rise (0.2 log) in anti-
streptolysin O (ASO) and/or anti-DNAse B titers.8 Further, did any
individuals with repeat positive GABHS throat cultures have
streptococcal typing to confirm they were not carriers? As should be
obvious by this time, diagnosing a new streptococcal infection may not
be straightforward.
Helm and Blackwood also raise the suggestion that a documented
response to antimicrobial treatment (present in three out of five
patients with PANDAS) might be an additional diagnostic clue.
Perhaps this could have been supported by providing comparable data
for children in the misdiagnosed group. Although the point is
interesting, it is physiologically unclear how an acute clinical
improvement can occur following the administration of an antibiotic
in a disorder proposed to be secondary to elevated anti-neuronal
antibodies.
In conclusion, this report raises a number of interesting issues and
serves to further our knowledge about a controversial topic. It also
shows that full knowledge about the details of the utilized diagnostic
criteria and the results of obtained clinical investigations are required
in order to further advance our understanding of this entity.
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